ARADIGM CORPORATION
Inhalation formulations of ciprofloxacin encapsulated in liposomes for lung delivery, including Lipoquin® (CFI) and Linhaliq® (DRCFI)
- Sector
- Medtech
- Headquarters
- HAYWARD, CA
- Latest Form D
- $23M, May 2016
- Total capital
- $28.1M
- Federal grants
- $973K
- 2 awards · 2017–2018
- Rank in peer group#475 of 477
- Private capital raised
- $27.1M
- 2 Form D · last May 2016
- 126 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 8
- 32 pending · first 2015
- Rank in peer group#35 of 477
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · In vitro and in vivo efficacy of liposomal ciprofloxacin formulations against Mycobacterium avium and Mycobacterium abscessus$486K
- Federal grantHealth and Human S · Phase II · In vitro and in vivo efficacy of liposomal ciprofloxacin formulations against Mycobacterium avium and Mycobacterium abscessus$487K
- Private capital raisedForm D · SEC · 2nd filing$23M
- Private capital raisedForm D · SEC · 1st filing$4.1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#35 · top 7%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Igor GondaResearcherExecutive Officer, DirectorLinked by 2 patents
- David D. BellDirectorNamed in SEC Form D filings
- Frank BarkerDirectorNamed in SEC Form D filings
- Frederick D. HudsonDirectorNamed in SEC Form D filings
- John M. SiebertDirectorNamed in SEC Form D filings
- Nancy E. PecotaExecutive OfficerNamed in SEC Form D filings
Show all 7 people
- Virgil ThompsonExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 8 granted of 40- PendingAntibiotic Formulations For Treating Of Cavity InfectionsUSPTOApplication 16748472
- GrantedConcentrated, Inhalable Ciprofloxacin FormulationUSPTOUS 10,420,765
- GrantedInhaled Surfactant-modified Liposomal Formulations Providing Both An Immediate And Sustained Release ProfileUSPTOUS 9,987,227
Show all 40 patent records
- Antibiotic Formulations For Treating Of Cavity InfectionsAug 13, 2020 · Application 16748472Pending
- Concentrated, Inhalable Ciprofloxacin FormulationSep 24, 2019 · US 10,420,765Granted
- Inhaled Surfactant-modified Liposomal Formulations Providing Both An Immediate And Sustained Release ProfileJun 5, 2018 · US 9,987,227Granted
- Novel Liposomal Formulations That Form Drug Nanocrystals After Freeze-thawMay 15, 2018 · US 9,968,555Granted
- Liposomal Ciprofloxacin Formulations With Encapsulated Ciprofloxacin NanocrystalsDec 19, 2017 · US 9,844,548Granted
- Diagnosis And Treatment Methods For Entry Of Gastrointestinal Contents Into Respiratory TractMar 14, 2017 · US 9,592,220Granted
- Pore Structures for Reduced Pressure AerosolizationDec 6, 2016 · US 9,511,199Granted
- Nanocrystals Formed In A MicroenvironmentMay 5, 2016 · Application 14993281Pending
- Concentrated, Inhalable Antibiotic FormulationFeb 16, 2016 · US 9,259,424Granted
- Concentrated, Inhalable Antibiotic FormulationJul 14, 2015 · US 9,078,897Granted
- Methods For Inhalation Of Smoke-free NicotineSep 18, 2014 · Application 14203096Pending
- Inhaled Surfactant-modified Liposomal Formulations Providing Both An Immediate And Sustained Release ProfileApplication 61894165Pending
- Ph-modulated Formulations For Pulmonary DeliveryApplication PCTUS2010022071Pending
- Deep Lung Pulmonary Delivery Of TreprostinilApplication PCTUS2009058217Pending
- Impinging Jet Nozzles In Stretched Or Deformed SubstratesApplication PCTUS2008011199Pending
- Burst Valve For Aerosol DeviceApplication PCTUS2008058367Pending
- Systems For Effecting Cessation Of Tobacco UseApplication PCTUS2007024641Pending
- Nicotine Formulations, Kits And Systems And Methods For Their UseApplication PCTUS2007024636Pending
- Dual Action, Inhaled Formulations Providing Both An Immediate And Sustained Release ProfileApplication PCTUS2007022424Pending
- Fluid Flow Regulating DeviceApplication PCTUS2007017292Pending
- Mechanical Single Dose Intrapulmonary Drug Delivery DevicesApplication PCTUS2007009468Pending
- Method And System For Laser MachiningApplication PCTUS2006038369Pending
- Device And Method For Generating An Aerosol From A Liquid Formulation And Ensuring Its SterilityApplication PCTUS2005036755Pending
- Compositions Methods And Systems For Pulmonary Delivery Of Recombinant Human Interferon ALPHA-2B And Other Therapeutic ProteinsApplication PCTUS2005030105Pending
- Method For Assaying Chemicals Deposited By A Chemical Delivery SystemApplication PCTUS2005012049Pending
- A Device For Readying A Needle Free Injector For DeliveryApplication PCTUS2004040937Pending
- Methods And Compositions For Treating Erectile DysfunctionApplication PCTUS2004029374Pending
- Method To Reduce Damage Caused By Irradiation Of Halogenated PolymersApplication PCTUS2004003594Pending
- A Method Of Proof Testing GlassApplication PCTUS2003040587Pending
- Aerosol Drug Delivery System Employing Formulation Pre-heatingApplication PCTUS2003029206Pending
- Method And Device For Non-destructive Analysis Of Perforations In A MaterialApplication PCTUS2003025455Pending
- Compositions Methods And Systems For Pulmonary Delivery Of Recombinant Human Interferon ALPHA-2BApplication PCTUS2003010832Pending
- System For Effecting Smoke CessationApplication PCTUS2003009284Pending
- Liposome-encapsulated Insulin FormulationsApplication PCTUS2002032201Pending
- Temperature Controlling Device For Aerosol Drug DeliveryApplication PCTUS2002028759Pending
- Method Of Generating Uniform Pores In Thin Polymer FilmsApplication PCTUS2002010339Pending
- Methods For Inhalation Of Smoke-free NicotineApplication 61794907Pending
- Aerosol Generation Using Sterile Multiple Dose ContainersApplication PCTUS2002008628Pending
- An Antibiotic Formulation For Use In Treating BronchiectasisApplication PCTUS2020014584Pending
- Antibiotic Formulations For Treatment Of Cavity InfectionsApplication 62930884Pending
Related companies, and why
- PREEMIE-PACER, LLCSimilar federal contract value in Medtech · null in contracts
- NUVAIRA, INC.Similar federal contract value in Medtech · null in contracts
- Sera PrognosticsSimilar federal contract value in Medtech · null in contracts
- Trevi Therapeutics, Inc.Similar federal contract value in Medtech · null in contracts
- ANDE CorpSimilar federal contract value in Medtech · null in contracts
- PAIGE.AI, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .